 SAN JOSE, Calif.--BUSINESS WIRE--Outset Medical, Inc. Nasdaq: OM Outset, a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the closing of its previously announced underwritten public offering of 2,945,864 shares of its common stock sold by Outset and 3,890,723 shares of its common stock sold by certain of its stockholders at a public offering price of 53.50 per share, which amounts include 891,728 share 